Henning Walczak

Dr. Henning Walczak


Research Focus & Metrics

Academic Career Length

35Years (1992-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2018 in Cell Death & Differentiation
Verified
Journal Article
Open access
Lorenzo GalluzziLorenzo Galluzzi
Lorenzo Galluzzi
IVIlio Vitale
Ilio Vitale
SAStuart A. Aaronson
Stuart A. Aaronson
JAJohn M. Abrams
John M. Abrams
DADieter Adam
Dieter Adam
Guido KroemerGuido Kroemer
Guido Kroemer
Over the past decade, the Nomenclature Committee on Cell Death (NCCD) has formulated guidelines for the definition and interpretation of cell death from morphological, biochemical, and functional perspectives. Since the field continues to expand and novel mechanisms that orchestrate multiple cell death pathways are unveiled, we propose an updated classification of cell death subroutines focusing on mechanistic and essential (as opposed to correlative and dispensable) aspects of the process. As we provide molecularly oriented definitions of terms including intrinsic apoptosis, extrinsic apoptosis, mitochondrial permeability transition (MPT)-driven necrosis, necroptosis, ferroptosis, pyroptosis, parthanatos, entotic cell death, NETotic cell death, lysosome-dependent cell death, autophagy-dependent cell death, immunogenic cell death, cellular senescence, and mitotic catastrophe, we discuss the utility of neologisms that refer to highly specialized instances of these processes. The mission of the NCCD is to provide a widely accepted nomenclature on cell death in support of the continued development of the field.

1 February 1999 in Nature Medicine
Verified
Journal Article
Closed access
HWHenning Walczak
Henning Walczak
RMRobert E. Miller
Robert E. Miller
KAKiley Ariail
Kiley Ariail
BGBrian Gliniak
Brian Gliniak
TGThomas S. Griffith
Thomas S. Griffith
DLDavid H. Lynch
David H. Lynch

23 January 2014 in Nature Reviews Molecular Cell Biology
Verified
Journal Article
Closed access
TBTom Vanden Berghe
Tom Vanden Berghe
ALAndreas Linkermann
Andreas Linkermann
SJSandrine Jouan-Lanhouet
Sandrine Jouan-Lanhouet
HWHenning Walczak
Henning Walczak
PVPeter Vandenabeele
Peter Vandenabeele

1 February 1995 in Nature
Verified
Journal Article
Closed access
JDJens Dhein
Jens Dhein
HWHenning Walczak
Henning Walczak
CBCaroline Bäumler
Caroline Bäumler
KDKlaus-Michael Debatin
Klaus-Michael Debatin
PKPeter H. Krammer
Peter H. Krammer

23 September 2011 in Nature Reviews Cancer
Verified
Journal Article
Closed access
PDF file
SVSebastian Vaughan
Sebastian Vaughan
JCJermaine I. Coward
Jermaine I. Coward
Robert BastRobert Bast
Robert Bast
ABAndy Berchuck
Andy Berchuck
JBJonathan S. Berek
Jonathan S. Berek
FBFrances R. Balkwill
Frances R. Balkwill

1 September 1997 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
HWHenning Walczak
Henning Walczak
MDMariapia A. Degli‐Esposti
Mariapia A. Degli‐Esposti
RJRichard S. Johnson
Richard S. Johnson
PSPam J. Smolak
Pam J. Smolak
JWJennifer Y. Waugh
Jennifer Y. Waugh
CRCharles T. Rauch
Charles T. Rauch
TRAIL is a member of the tumor necrosis factor (TNF) family of cytokines and induces apoptosis in a wide variety of cells. Based on homology searching of a private database, a receptor for TRAIL (DR4 or TRAIL‐R1) was recently identified. Here we report the identification of a distinct receptor for TRAIL, TRAIL‐R2, by ligand‐based affinity purification and subsequent molecular cloning. TRAIL‐R2 was purified independently as the only receptor for TRAIL detectable on the surface of two different human cell lines that undergo apoptosis upon stimulation with TRAIL. TRAIL‐R2 contains two extracellular cysteine‐rich repeats, typical for TNF receptor (TNFR) family members, and a cytoplasmic death domain. TRAIL binds to recombinant cell‐surface‐expressed TRAIL‐R2, and TRAIL‐induced apoptosis is inhibited by a TRAIL‐R2–Fc fusion protein. TRAIL‐R2 mRNA is widely expressed and the gene encoding TRAIL‐R2 is located on human chromosome 8p22‐21. Like TRAIL‐R1, TRAIL‐R2 engages a caspase‐dependent apoptotic pathway but, in contrast to TRAIL‐R1, TRAIL‐R2 mediates apoptosis via the intracellular adaptor molecule FADD/MORT1. The existence of two distinct receptors for the same ligand suggests an unexpected complexity to TRAIL biology, reminiscent of dual receptors for TNF, the canonical member of this family.